Endometriosis Treatment Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: E72794A2B9BDEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn’t a complete cure for this condition, effective endometriosis treatment is provided through medication which suppresses the extreme pain suffered during endometriosis. There are many assumptions to be taken in order to estimate the correct prevalence of endometriosis patients. The absolute prevalent population is always limited as most cases in developing regions are not reported. Also, the awareness and understanding of different scales of pain is very limited in most regions. Hence, cases of endometriosis often get ignored. The situation persists in not only developing or poor socio-economic countries, but developed countries like the UK, where it is assumed that around 2 million women have undiagnosed endometriosis.

This report contains market size and forecasts of Endometriosis Treatment Drugs in global, including the following market information:

Global Endometriosis Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Endometriosis Treatment Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Endometriosis Treatment Drugs companies in 2021 (%)

The global Endometriosis Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Endometriosis Treatment Drugs include AbbVie Inc, Bayer AG, AstraZeneca, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc and Debiopharm Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Endometriosis Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Endometriosis Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Endometriosis Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
  • Oral Type
  • Others
Global Endometriosis Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Endometriosis Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • Others
Global Endometriosis Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Endometriosis Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Endometriosis Treatment Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Endometriosis Treatment Drugs revenues share in global market, 2021 (%)

Key companies Endometriosis Treatment Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Endometriosis Treatment Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • AbbVie Inc
  • Bayer AG
  • AstraZeneca
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • Ipsen Pharma
  • Myovant Sciences Ltd
  • Endoceutics, Inc
  • Debiopharm Group
  • Mayne Pharma Group
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Endometriosis Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Endometriosis Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENDOMETRIOSIS TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Endometriosis Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Endometriosis Treatment Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Endometriosis Treatment Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Endometriosis Treatment Drugs Players in Global Market
3.2 Top Global Endometriosis Treatment Drugs Companies Ranked by Revenue
3.3 Global Endometriosis Treatment Drugs Revenue by Companies
3.4 Global Endometriosis Treatment Drugs Sales by Companies
3.5 Global Endometriosis Treatment Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Endometriosis Treatment Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Endometriosis Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Endometriosis Treatment Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Endometriosis Treatment Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Endometriosis Treatment Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Endometriosis Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral Type
  4.1.3 Others
4.2 By Type - Global Endometriosis Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Endometriosis Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Endometriosis Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Endometriosis Treatment Drugs Sales & Forecasts
  4.3.1 By Type - Global Endometriosis Treatment Drugs Sales, 2017-2022
  4.3.2 By Type - Global Endometriosis Treatment Drugs Sales, 2023-2028
  4.3.3 By Type - Global Endometriosis Treatment Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Endometriosis Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Endometriosis Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 E-Commerce
  5.1.5 Others
5.2 By Application - Global Endometriosis Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Endometriosis Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Endometriosis Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Endometriosis Treatment Drugs Sales & Forecasts
  5.3.1 By Application - Global Endometriosis Treatment Drugs Sales, 2017-2022
  5.3.2 By Application - Global Endometriosis Treatment Drugs Sales, 2023-2028
  5.3.3 By Application - Global Endometriosis Treatment Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Endometriosis Treatment Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Endometriosis Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Endometriosis Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Endometriosis Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Endometriosis Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Endometriosis Treatment Drugs Sales & Forecasts
  6.3.1 By Region - Global Endometriosis Treatment Drugs Sales, 2017-2022
  6.3.2 By Region - Global Endometriosis Treatment Drugs Sales, 2023-2028
  6.3.3 By Region - Global Endometriosis Treatment Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Endometriosis Treatment Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Endometriosis Treatment Drugs Sales, 2017-2028
  6.4.3 US Endometriosis Treatment Drugs Market Size, 2017-2028
  6.4.4 Canada Endometriosis Treatment Drugs Market Size, 2017-2028
  6.4.5 Mexico Endometriosis Treatment Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Endometriosis Treatment Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Endometriosis Treatment Drugs Sales, 2017-2028
  6.5.3 Germany Endometriosis Treatment Drugs Market Size, 2017-2028
  6.5.4 France Endometriosis Treatment Drugs Market Size, 2017-2028
  6.5.5 U.K. Endometriosis Treatment Drugs Market Size, 2017-2028
  6.5.6 Italy Endometriosis Treatment Drugs Market Size, 2017-2028
  6.5.7 Russia Endometriosis Treatment Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Endometriosis Treatment Drugs Market Size, 2017-2028
  6.5.9 Benelux Endometriosis Treatment Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Endometriosis Treatment Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Endometriosis Treatment Drugs Sales, 2017-2028
  6.6.3 China Endometriosis Treatment Drugs Market Size, 2017-2028
  6.6.4 Japan Endometriosis Treatment Drugs Market Size, 2017-2028
  6.6.5 South Korea Endometriosis Treatment Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Endometriosis Treatment Drugs Market Size, 2017-2028
  6.6.7 India Endometriosis Treatment Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Endometriosis Treatment Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Endometriosis Treatment Drugs Sales, 2017-2028
  6.7.3 Brazil Endometriosis Treatment Drugs Market Size, 2017-2028
  6.7.4 Argentina Endometriosis Treatment Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Endometriosis Treatment Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Endometriosis Treatment Drugs Sales, 2017-2028
  6.8.3 Turkey Endometriosis Treatment Drugs Market Size, 2017-2028
  6.8.4 Israel Endometriosis Treatment Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Endometriosis Treatment Drugs Market Size, 2017-2028
  6.8.6 UAE Endometriosis Treatment Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AbbVie Inc
  7.1.1 AbbVie Inc Corporate Summary
  7.1.2 AbbVie Inc Business Overview
  7.1.3 AbbVie Inc Endometriosis Treatment Drugs Major Product Offerings
  7.1.4 AbbVie Inc Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 AbbVie Inc Key News
7.2 Bayer AG
  7.2.1 Bayer AG Corporate Summary
  7.2.2 Bayer AG Business Overview
  7.2.3 Bayer AG Endometriosis Treatment Drugs Major Product Offerings
  7.2.4 Bayer AG Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Bayer AG Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Endometriosis Treatment Drugs Major Product Offerings
  7.3.4 AstraZeneca Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Pfizer Inc
  7.4.1 Pfizer Inc Corporate Summary
  7.4.2 Pfizer Inc Business Overview
  7.4.3 Pfizer Inc Endometriosis Treatment Drugs Major Product Offerings
  7.4.4 Pfizer Inc Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Pfizer Inc Key News
7.5 Teva Pharmaceutical Industries Ltd
  7.5.1 Teva Pharmaceutical Industries Ltd Corporate Summary
  7.5.2 Teva Pharmaceutical Industries Ltd Business Overview
  7.5.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Major Product Offerings
  7.5.4 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Teva Pharmaceutical Industries Ltd Key News
7.6 Ipsen Pharma
  7.6.1 Ipsen Pharma Corporate Summary
  7.6.2 Ipsen Pharma Business Overview
  7.6.3 Ipsen Pharma Endometriosis Treatment Drugs Major Product Offerings
  7.6.4 Ipsen Pharma Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Ipsen Pharma Key News
7.7 Myovant Sciences Ltd
  7.7.1 Myovant Sciences Ltd Corporate Summary
  7.7.2 Myovant Sciences Ltd Business Overview
  7.7.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Major Product Offerings
  7.7.4 Myovant Sciences Ltd Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Myovant Sciences Ltd Key News
7.8 Endoceutics, Inc
  7.8.1 Endoceutics, Inc Corporate Summary
  7.8.2 Endoceutics, Inc Business Overview
  7.8.3 Endoceutics, Inc Endometriosis Treatment Drugs Major Product Offerings
  7.8.4 Endoceutics, Inc Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Endoceutics, Inc Key News
7.9 Debiopharm Group
  7.9.1 Debiopharm Group Corporate Summary
  7.9.2 Debiopharm Group Business Overview
  7.9.3 Debiopharm Group Endometriosis Treatment Drugs Major Product Offerings
  7.9.4 Debiopharm Group Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Debiopharm Group Key News
7.10 Mayne Pharma Group
  7.10.1 Mayne Pharma Group Corporate Summary
  7.10.2 Mayne Pharma Group Business Overview
  7.10.3 Mayne Pharma Group Endometriosis Treatment Drugs Major Product Offerings
  7.10.4 Mayne Pharma Group Endometriosis Treatment Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Mayne Pharma Group Key News

8 GLOBAL ENDOMETRIOSIS TREATMENT DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Endometriosis Treatment Drugs Production Capacity, 2017-2028
8.2 Endometriosis Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Endometriosis Treatment Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ENDOMETRIOSIS TREATMENT DRUGS SUPPLY CHAIN ANALYSIS

10.1 Endometriosis Treatment Drugs Industry Value Chain
10.2 Endometriosis Treatment Drugs Upstream Market
10.3 Endometriosis Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Endometriosis Treatment Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Endometriosis Treatment Drugs in Global Market
Table 2. Top Endometriosis Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Endometriosis Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Endometriosis Treatment Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Endometriosis Treatment Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Endometriosis Treatment Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Endometriosis Treatment Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Endometriosis Treatment Drugs Product Type
Table 9. List of Global Tier 1 Endometriosis Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endometriosis Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Endometriosis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Endometriosis Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Endometriosis Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Endometriosis Treatment Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Endometriosis Treatment Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Endometriosis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Endometriosis Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Endometriosis Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Endometriosis Treatment Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Endometriosis Treatment Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Endometriosis Treatment Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Endometriosis Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Endometriosis Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Endometriosis Treatment Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Endometriosis Treatment Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Endometriosis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Endometriosis Treatment Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Endometriosis Treatment Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Endometriosis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Endometriosis Treatment Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Endometriosis Treatment Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Endometriosis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Endometriosis Treatment Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Endometriosis Treatment Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Endometriosis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Endometriosis Treatment Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Endometriosis Treatment Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Endometriosis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Endometriosis Treatment Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Endometriosis Treatment Drugs Sales, (K Units), 2023-2028
Table 46. AbbVie Inc Corporate Summary
Table 47. AbbVie Inc Endometriosis Treatment Drugs Product Offerings
Table 48. AbbVie Inc Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bayer AG Corporate Summary
Table 50. Bayer AG Endometriosis Treatment Drugs Product Offerings
Table 51. Bayer AG Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Endometriosis Treatment Drugs Product Offerings
Table 54. AstraZeneca Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Pfizer Inc Corporate Summary
Table 56. Pfizer Inc Endometriosis Treatment Drugs Product Offerings
Table 57. Pfizer Inc Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 59. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Offerings
Table 60. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Ipsen Pharma Corporate Summary
Table 62. Ipsen Pharma Endometriosis Treatment Drugs Product Offerings
Table 63. Ipsen Pharma Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Myovant Sciences Ltd Corporate Summary
Table 65. Myovant Sciences Ltd Endometriosis Treatment Drugs Product Offerings
Table 66. Myovant Sciences Ltd Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Endoceutics, Inc Corporate Summary
Table 68. Endoceutics, Inc Endometriosis Treatment Drugs Product Offerings
Table 69. Endoceutics, Inc Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Debiopharm Group Corporate Summary
Table 71. Debiopharm Group Endometriosis Treatment Drugs Product Offerings
Table 72. Debiopharm Group Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Mayne Pharma Group Corporate Summary
Table 74. Mayne Pharma Group Endometriosis Treatment Drugs Product Offerings
Table 75. Mayne Pharma Group Endometriosis Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Endometriosis Treatment Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Endometriosis Treatment Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Endometriosis Treatment Drugs Production by Region, 2017-2022 (K Units)
Table 79. Global Endometriosis Treatment Drugs Production by Region, 2023-2028 (K Units)
Table 80. Endometriosis Treatment Drugs Market Opportunities & Trends in Global Market
Table 81. Endometriosis Treatment Drugs Market Drivers in Global Market
Table 82. Endometriosis Treatment Drugs Market Restraints in Global Market
Table 83. Endometriosis Treatment Drugs Raw Materials
Table 84. Endometriosis Treatment Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Endometriosis Treatment Drugs Downstream
Table 86. Endometriosis Treatment Drugs Downstream Clients in Global Market
Table 87. Endometriosis Treatment Drugs Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Endometriosis Treatment Drugs Segment by Type
Figure 2. Endometriosis Treatment Drugs Segment by Application
Figure 3. Global Endometriosis Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Endometriosis Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Endometriosis Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Endometriosis Treatment Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Endometriosis Treatment Drugs Revenue in 2021
Figure 9. By Type - Global Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Endometriosis Treatment Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Endometriosis Treatment Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 19. US Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 24. Germany Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 33. China Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Endometriosis Treatment Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Endometriosis Treatment Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Endometriosis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Endometriosis Treatment Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Endometriosis Treatment Drugs by Region, 2021 VS 2028
Figure 50. Endometriosis Treatment Drugs Industry Value Chain
Figure 51. Marketing Channels


More Publications